Abstract
Tissue Engineering (or regenerative medicine) is a rapidly developing field of research pursued by very different branches of medicine. The most results are published by orthopedists [28] and cardiologists, but meanwhile, there is nearly no special subject that does not investigate in this area. Furthermore, there is a multitude of methods and techniques that are involved in tissue engineering. Therefore, it is difficult to define or to describe the scope of “tissue engineering” in one sentence.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
ABIM, ACP-ASIM, European Federation of Internal Medicine (2002) Medical professionalism in the new millennium. A physician charter. Ann Internal Med 136(3):243–246
Abouna GM (2003) Ethical issues in organ and tissue transplantation. Med Princ Pract 12(1):54–69
Ach JS, Jömann N (2006) Ethical implications of nanobiotechnology. State-of-the-art survey of ethical issues related to nanobiotechnology. In: Siep L (eds) Nano-bio-ethics: ethical dimensions of nanobiotechnology. Münster, Germany: Lit pp 13–62
Baum BJ, Mooney DJ (2000) The impact of tissue engineering on dentistry. J Am Dental Assoc 131:309–318
Beauchamp TL, Childress JF (1994) Principles of biomedical ethics, 4th ed. Oxford University Press, New York
Birnbacher D (2007) Der Hirntod—eine pragmatische Verteidigung. Jahrbuch für Recht und Ethik 15:459–477
Black J (1997) Thinking twice about “tissue engineering”. IEEE Eng Med Biol Mag 16(4):102–104
Buchanan AE, Brock DW (1990) Deciding for others: the ethics of surrogate decision making. University Press, Cambridge
Daar AS, Bhatt A, Court E, Singer A (2004) Stem cell research and transplantation: science leading ethics. Transplant Proc 36:2504–2506
de Brugerolle A (2007) SkinEthic Laboratories, a company devoted to develop and produce In vitro alternative methods to anima use. ALTEX 24(3):167–171
Denker HW (1999) Embryonic stem cells: an exciting field for basic research and tissue engineering, but also an ethical dilemma? Cells Tissues Organs 165:246–249
Dickens BM, Cook RJ (2007) Acquiring human embryos for stem cell research. Int J Gynaecol Obstet 96:67–71
European Group on Ethics (2004) Report of the European Group on Ethics on the Ethical Aspects of Human Tissue Engineered Products
Eyrich D, Brandl F, Appel B, Wiese H, Maier G, Wenzel M, Staudenmaier R, Goepferich A, Blunk T (2007) Long-term stable fibrin gels for cartilage engineering. Biomaterials 28:55–65
Faden RR, Beauchamp TL (1986) A history and theory of informed consent. Oxford, New York
Gelhaus P (2006) Gentherapie und Weltanschauung. Ein Überblick über die genethische Discussion. Wissenschaftlicher Buchverlag, Darmstadt
Gelhaus P (2007) Was bedeutet eigentlich “gesund” im medizinischen Umfeld? In: Jansen G, Schwarzfischer K (eds) Gesundheit-wozu? Jansen-Verlag, Lüneburg, pp 83–102
Gelhaus P (2008) Wie groß ist zu groß? Zur Funktionalität des Normalen. In: Groß D, Müller S, Steinmetzer J (eds) Normal—anders—krank? Akzeptanz, Stigmatisierung und Pathologisierung im Kontext der Medizin. Medizinisch-Wissenschaftliche Verlagsgesellschaft Berlin, pp 33–49
Gelhaus P, Middel CD (2002) “Individuelle Gesundheit versus public health?!” ein Streitgespräch zur Forschungsentwicklung am Beispiel der revidierten Deklaration von Helsinki (Edinburgh 2000). In: Brand A, Engelhardt DV, Simon A, Wehkamp KH, (eds) Individuelle Gesundheit versus public health? Münster, London, pp 96–112
Gordijn B (2004) Medizinische Utopien. Eine ethische Betrachtung. Vandenhoeck & Ruprecht Göttingen, pp 65–110
Green RM (2002) Benefiting from “evil”: an incipient moral problem in human stem cell research. Bioethics 16(6):544–556
Green RM (2004) Ethical considerations. In: Lanza R, et al. (eds) Handbook of stem cells. Elsevier, Amsterdam, pp 759–764
Hammerman MR, Cortesini R (2004) Organogenesis and tissue engineering.Transpl Immunol 12:191–192
Heinonen M, Oila O, Nordström K (2005) Current issues in the regulation of human tissue-engineering products in the European Union. Tissue Eng 11(11/12):1905–1911
Henon PR:(2003) Human embryonic or adult stem cells: an overview on ethics and perspectives for tissue engineering. Adv Exp Med Biol 534:27–45
Hunziker EB (2003) Tissue engineering of bone and cartilage. From the preclinical model to the patient. Novartis Found Symp 249:70–78
Langer R, Vacanti JP (1993) Tissue engineering. Science 260:920–926
Lohmander LS (2003) Tissue engineering of cartilage: do we need it, can we do it, is it good and can we prove it? Novartis Found Symp 249:2–10
Longley D, Lawford P (2001) Engineering human tissue and regulation: confronting biology and law to bridge the gaps. Med Law Int 5:101–115
Meyer T (2005) Ethical considerations in bone and cartilage tissue engineering. Meyer U, Wiesmann HP (eds) Bone and cartilage engineering. Springer, Berlin, pp 203–206
Nationaler Ethikrat (Germany) (2007) Zur Frage einer Änderung des Stammzellgesetzes. Stellungnahme, www.ethikrat.org/stellungnahmen/pdf/stn-stammzellgesetz.pdf (access: 03–06–2008)
Nordgren A (2004) Moral imagination in tissue engineering research on animal models. Biomaterials 25:1723–1734
Reed JA, Patarca R (2006) Regenerative dental medicine: stem cells and tissue engineering in dentistry. J Environ Pathol Toxicol Oncol 25(3):537–569
San Martin A, Borlongan CV (2006) Cell transplantation: toward cell therapy. Cell Transplant 15:665–673
Satava RM (2002) Disruptive visions. Moral and ethical challenges from advanced technologies and issues for the new generation of surgeons. Surg Endosc 16:1403–1408
Satava RM (2003) Biomedical, ethical, and moral issues being forced by advanced medical technologies. Proc Am Philos Soc 147(3):246–258
Schilling AF, Linhart W, Filke S, Gebauer M, Schinke T, Rueger JM, Amling M (2004) Resorbability of bone substitute biomaterials by human osteoclasts. Biomaterials 25:3963–3972
Schöne-Seifert B, Ach JS, Siep L (2006) Totipotenz und Potentialität. Zum moralischen Status von Embryonen bei unterschiedlichen Varianten der Gewinnung humaner embryonaler Stammzellen. Gutachten für das Kompetenznetzwerk Stammzellforschung NRW. Jahrbuch für Wissenschaft und Ethik 11:261–321
Schwab IR, Johnson NT, Harkin DG (2006) Inherent risks associated with manufacture of bioengineered ocular surface tissue. Arch Ophtalmol 124:1734–1740
Siep L (2006) Ethical problems of stem cell research and stem cell transplantation, In: Deltas C, Kalokairinou EM, Rogge S (eds) Progress in science and the danger of hybris. Waxmann, Münster, pp 91–99
Singer P (1975) Animal liberation: a new ethics for our treatment of animals. Random House, New York
Singer P (1993) Practical Ethics 2nd ed. Cambridge, New York
Stanworth SJ, Newland AC (2001) Stem cells: progress in research and edging towards the clinical setting. Clin Med 1(5):378–382
Steinbock B (2007) Moral status, moral value and human embryos: implications for stem cell research. In: Steinbock B (ed) The Oxford handbook of bioethics. Oxford, New York, pp 416–440
Sutherland FWH, Mayer JE Jr (2003) Ethical and regulatory issues concerning engineered tissues for congenital heart repair. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 6:152–163
Sylvester KG, Longaker MT (2004) Stem cells. Arch Surg 139:93–99
Takala T, Häyry M (2007) Benefiting from past wrongdoing, human embryonic stem cells and the fragility of the German legal position. Bioethics 21:150–159
Trommelmans L, Selling J, Dierickx K (2007) A critical assessment of the directive on tissue engineering of the European Union. Tissue Eng 13(4):667–672
Vats A, Tolley NS, Polak JM, Buttery LDK (2002) Stem cells: sources and applications. Clin Otolaryngol Allied Sci 27:227–232
Weyr S (1993) Informed consent: patient autonomy and physician beneficence within clinical medicine. Kluwer, Dordrecht
Williams D (2006) A registry for tissue engineering clinical trials, In: Med Device Technol 5:8–10
World Medical Association (1964, 1975, 1983, 1989, 1996, 2000, 2004) Declaration of Helsinki
Zoloth L (2004) Immortal cells, moral selves. In: Lanza R, et al. (eds.) Handbook of stem cells, vol 1. Elsevier, Amsterdam, pp 747–757
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gelhaus, P. (2009). Ethical Issues in Tissue Engineering. In: Meyer, U., Handschel, J., Wiesmann, H., Meyer, T. (eds) Fundamentals of Tissue Engineering and Regenerative Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-77755-7_3
Download citation
DOI: https://doi.org/10.1007/978-3-540-77755-7_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-77754-0
Online ISBN: 978-3-540-77755-7
eBook Packages: MedicineMedicine (R0)